Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Fungus – except allergen – or component thereof or substance...
Reexamination Certificate
2007-09-04
2007-09-04
Devi, S. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Fungus, except allergen, or component thereof or substance...
C424S094500, C424S193100, C514S002600
Reexamination Certificate
active
10873583
ABSTRACT:
Infection byP. cariniican be treated by administering methioninase optionally in combination with additional therapeutic agents, such as antibiotics.
REFERENCES:
patent: 5690292 (1997-11-01), Sano
patent: 5690929 (1997-11-01), Lishko et al.
patent: 5715835 (1998-02-01), Lishko et al.
patent: 5888506 (1999-03-01), Tan
patent: 5891704 (1999-04-01), Tan
patent: 6231854 (2001-05-01), Tan
patent: 6461851 (2002-10-01), Tan
patent: 6524571 (2003-02-01), Xu et al.
patent: 2002/0035090 (2002-03-01), Zeldis et al.
Merali et al., J. Biol. Chem. (2000) 275: 14958-14963.
Skelly et al., Lancet (2003) 361: 1267-1268.
Invitation to Pay Additional Fees for PCT/US04/19989, mailed on Sep. 30, 2004, 2 pages.
Han Qinghong
Li Shukuan
Sun Xinghua
Tan Yuying
Xu Mingxu
Anti-Cancer, Inc.
Devi S.
Morrison & Foerster / LLP
LandOfFree
Lyase treatment for P. carinii does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Lyase treatment for P. carinii, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lyase treatment for P. carinii will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3769883